Literature DB >> 21163582

Progesterone receptor antagonist CDB-4124 increases depression-like behavior in mice without affecting locomotor ability.

Ethan H Beckley1, Angela C Scibelli, Deborah A Finn.   

Abstract

Progesterone withdrawal has been proposed as an underlying factor in premenstrual syndrome and postpartum depression. Progesterone withdrawal induces forced swim test (FST) immobility in mice, a depression-like behavior, but the contribution of specific receptors to this effect is unclear. The role of progesterone's GABA(A) receptor-modulating metabolite allopregnanolone in depression- and anxiety-related behaviors has been extensively documented, but little attention has been paid to the role of progesterone receptors. We administered the classic progesterone receptor antagonist mifepristone (RU-38486) and the specific progesterone receptor antagonist CDB-4124 to mice that had been primed with progesterone for five days, and found that both compounds induced FST immobility reliably, robustly, and in a dose-dependent fashion. Although CDB-4124 increased FST immobility, it did not suppress initial activity in a locomotor test. These findings suggest that decreased progesterone receptor activity contributes to depression-like behavior in mice, consistent with the hypothesis that progesterone withdrawal may contribute to the symptoms of premenstrual syndrome or postpartum depression.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21163582      PMCID: PMC3081939          DOI: 10.1016/j.psyneuen.2010.11.004

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  66 in total

1.  Anhedonia in postpartum rats.

Authors:  Brittany M Navarre; Jillian D Laggart; Rebecca M Craft
Journal:  Physiol Behav       Date:  2010-01-12

2.  CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914.

Authors:  Barbara J Attardi; Janet Burgenson; Sheri A Hild; Jerry R Reel; Richard P Blye
Journal:  Mol Cell Endocrinol       Date:  2002-02-25       Impact factor: 4.102

3.  Expression of intracellular progesterone receptors in rat brain during different reproductive states, and involvement in maternal behavior.

Authors:  M Numan; J K Roach; M C del Cerro; A Guillamón; S Segovia; T P Sheehan; M J Numan
Journal:  Brain Res       Date:  1999-06-05       Impact factor: 3.252

4.  Lack of effect of induced menses on symptoms in women with premenstrual syndrome.

Authors:  P J Schmidt; L K Nieman; G N Grover; K L Muller; G R Merriam; D R Rubinow
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

5.  Clinical and biological effects of mifepristone treatment for psychotic depression.

Authors:  Benjamin H Flores; Heather Kenna; Jennifer Keller; Hugh Brent Solvason; Alan F Schatzberg
Journal:  Neuropsychopharmacology       Date:  2006-03       Impact factor: 7.853

6.  Repeated electroconvulsive stimuli have long-lasting effects on hippocampal BDNF and decrease immobility time in the rat forced swim test.

Authors:  Bingjin Li; Katsuya Suemaru; Ranji Cui; Hiroaki Araki
Journal:  Life Sci       Date:  2007-01-27       Impact factor: 5.037

7.  Sequential inhibition of progesterone: effects on sexual receptivity and associated changes in brain cytosol progestin binding in the female rat.

Authors:  B Parsons; M Y McGinnis; B S McEwen
Journal:  Brain Res       Date:  1981-09-21       Impact factor: 3.252

8.  Withdrawal effects from progesterone and estradiol relate to individual risk-taking and explorative behavior in female rats.

Authors:  Magnus Löfgren; Inga-Maj Johansson; Bengt Meyerson; Sahruh Turkmen; Torbjörn Bäckström
Journal:  Physiol Behav       Date:  2008-08-28

9.  Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine.

Authors:  Andréy Mazarati; Prabha Siddarth; Roger A Baldwin; Don Shin; Rochelle Caplan; Raman Sankar
Journal:  Brain       Date:  2008-06-17       Impact factor: 13.501

10.  Antidepressant efficacy screening of novel targets in the chick anxiety-depression model.

Authors:  Kenneth J Sufka; Jason E Warnick; Cassan N Pulaski; Stephen R Slauson; Young B Kim; John M Rimoldi
Journal:  Behav Pharmacol       Date:  2009-03       Impact factor: 2.293

View more
  7 in total

1.  Relationship Between Postpartum Depression and Psychological and Biological Variables in the Initial Postpartum Period.

Authors:  Dolores Marín-Morales; Susana Toro-Molina; Cecilia Peñacoba-Puente; Marta Losa-Iglesias; Francisco Javier Carmona-Monge
Journal:  Matern Child Health J       Date:  2018-06

Review 2.  Progesterone, reproduction, and psychiatric illness.

Authors:  Lindsay R Standeven; Katherine O McEvoy; Lauren M Osborne
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2020-06-18       Impact factor: 5.237

3.  An antiprogestin, CDB4124, blocks progesterone's attenuation of the negative effects of a mild stress on sexual behavior.

Authors:  Lynda Uphouse; Cindy Hiegel
Journal:  Behav Brain Res       Date:  2012-11-12       Impact factor: 3.332

4.  The selective glucocorticoid receptor antagonist CORT 108297 decreases neuroendocrine stress responses and immobility in the forced swim test.

Authors:  Matia B Solomon; Aynara C Wulsin; Taylor Rice; Dayna Wick; Brent Myers; Jessica McKlveen; Jonathan N Flak; Yvonne Ulrich-Lai; James P Herman
Journal:  Horm Behav       Date:  2014-02-11       Impact factor: 3.587

Review 5.  Is progesterone a worthy candidate as a novel therapy for traumatic brain injury?

Authors:  Donald G Stein
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

6.  Sex-specific effects of neonatal progestin receptor antagonism on juvenile social play behavior in rats.

Authors:  R M Forbes-Lorman
Journal:  Behav Brain Funct       Date:  2021-11-05       Impact factor: 3.759

Review 7.  The role of brain-derived neurotrophic factor in comorbid depression: possible linkage with steroid hormones, cytokines, and nutrition.

Authors:  Tadahiro Numakawa; Misty Richards; Shingo Nakajima; Naoki Adachi; Miyako Furuta; Haruki Odaka; Hiroshi Kunugi
Journal:  Front Psychiatry       Date:  2014-09-26       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.